Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cell Stem Cell | journal | 12.633 Q1 | 305 | 199 | 550 | 7377 | 8844 | 460 | 15.61 | 37.07 | 39.28 | |
2 | Pharmacological Reviews | journal | 10.673 Q1 | 254 | 36 | 74 | 12166 | 1847 | 74 | 25.95 | 337.94 | 38.46 | |
3 | Stem Cells | journal | 4.083 Q1 | 253 | 273 | 749 | 13578 | 6809 | 710 | 8.70 | 49.74 | 40.16 | |
4 | Molecular Therapy | journal | 3.234 Q1 | 209 | 269 | 800 | 11010 | 5579 | 693 | 6.88 | 40.93 | 40.67 | |
5 | ACS Chemical Biology | journal | 2.991 Q1 | 135 | 232 | 389 | 10857 | 2107 | 354 | 5.27 | 46.80 | 33.96 | |
6 | Cell Chemical Biology | journal | 2.809 Q1 | 206 | 194 | 534 | 8184 | 2632 | 486 | 4.91 | 42.19 | 30.81 | |
7 | Medicinal Research Reviews | journal | 2.488 Q1 | 150 | 38 | 76 | 6847 | 646 | 74 | 7.59 | 180.18 | 32.73 | |
8 | Molecular Pharmacology | journal | 2.471 Q1 | 210 | 203 | 719 | 9301 | 3975 | 719 | 5.05 | 45.82 | 34.01 | |
9 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 2.379 Q1 | 151 | 161 | 264 | 6872 | 2275 | 257 | 8.44 | 42.68 | 33.41 | |
10 | Journal of Medicinal Chemistry | journal | 2.343 Q1 | 301 | 886 | 2276 | 42637 | 13433 | 2271 | 5.94 | 48.12 | 34.95 | |
11 | Molecular Pharmaceutics | journal | 2.152 Q1 | 156 | 349 | 657 | 15735 | 3998 | 644 | 5.42 | 45.09 | 34.06 | |
12 | NeuroMolecular Medicine | journal | 1.932 Q1 | 82 | 30 | 109 | 2399 | 538 | 107 | 4.63 | 79.97 | 36.63 | |
13 | Molecular Medicine | journal | 1.928 Q1 | 133 | 155 | 265 | 5883 | 1335 | 258 | 4.96 | 37.95 | 40.00 | |
14 | Pharmaceutical Research | journal | 1.895 Q1 | 229 | 277 | 787 | 11163 | 4523 | 742 | 5.50 | 40.30 | 31.46 | |
15 | Journal of Pharmacology and Experimental Therapeutics | journal | 1.689 Q1 | 244 | 340 | 1319 | 14533 | 5977 | 1312 | 4.44 | 42.74 | 36.01 | |
16 | American Journal of Translational Research (discontinued) | journal | 1.504 Q2 | 80 | 40 | 121 | 1821 | 501 | 117 | 4.42 | 45.53 | 35.94 | |
17 | BioFactors | journal | 1.504 Q2 | 113 | 58 | 183 | 3444 | 907 | 175 | 3.72 | 59.38 | 43.06 | |
18 | Cancer Biology and Therapy | journal | 1.478 Q2 | 130 | 175 | 956 | 7253 | 2962 | 743 | 3.15 | 41.45 | 39.91 | |
19 | Journal of Natural Products | journal | 1.428 Q2 | 161 | 330 | 1210 | 10465 | 4382 | 1187 | 3.64 | 31.71 | 36.27 | |
20 | Molecular Interventions | journal | 1.426 Q2 | 78 | 0 | 96 | 0 | 325 | 83 | 3.66 | 0.00 | 0.00 | |
21 | Human Gene Therapy | journal | 1.382 Q2 | 159 | 130 | 460 | 5063 | 1802 | 415 | 3.90 | 38.95 | 37.18 | |
22 | Pharmacogenetics and Genomics | journal | 1.230 Q2 | 152 | 98 | 324 | 4023 | 1394 | 322 | 3.96 | 41.05 | 35.08 | |
23 | Journal of Cardiovascular Translational Research | journal | 1.198 Q2 | 60 | 84 | 239 | 5662 | 712 | 224 | 3.46 | 67.40 | 35.21 | |
24 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 1.184 Q2 | 70 | 55 | 183 | 3321 | 471 | 178 | 2.40 | 60.38 | 35.11 | |
25 | Molecular Imaging | journal | 1.124 Q2 | 66 | 50 | 111 | 1660 | 408 | 109 | 3.54 | 33.20 | 30.59 | |
26 | Vascular Pharmacology | journal | 1.106 Q2 | 108 | 68 | 189 | 4369 | 597 | 182 | 3.44 | 64.25 | 39.30 | |
27 | OMICS A Journal of Integrative Biology | journal | 1.054 Q2 | 69 | 72 | 217 | 3406 | 677 | 200 | 3.10 | 47.31 | 36.89 | |
28 | Blood Cells, Molecules, and Diseases | journal | 0.987 Q2 | 98 | 69 | 326 | 2469 | 791 | 279 | 2.29 | 35.78 | 49.10 | |
29 | Journal of Biomolecular Screening | journal | 0.964 Q2 | 86 | 132 | 378 | 3861 | 943 | 373 | 2.43 | 29.25 | 40.21 | |
30 | Nuclear Medicine and Biology | journal | 0.943 Q3 | 98 | 158 | 356 | 5107 | 1057 | 349 | 2.92 | 32.32 | 28.02 | |
31 | Nucleic Acid Therapeutics | journal | 0.920 Q3 | 77 | 51 | 124 | 2221 | 360 | 121 | 2.63 | 43.55 | 34.41 | |
32 | Viral Immunology | journal | 0.855 Q3 | 70 | 62 | 192 | 2297 | 353 | 170 | 1.77 | 37.05 | 37.57 | |
33 | Journal of Gene Medicine | journal | 0.841 Q3 | 100 | 69 | 274 | 3001 | 743 | 263 | 2.42 | 43.49 | 37.97 | |
34 | Assay and Drug Development Technologies | journal | 0.834 Q3 | 65 | 89 | 262 | 1729 | 308 | 151 | 1.04 | 19.43 | 30.32 | |
35 | Chemistry and Biodiversity | journal | 0.611 Q3 | 83 | 215 | 594 | 9598 | 1277 | 590 | 2.11 | 44.64 | 38.89 | |
36 | Journal of Biochemical and Molecular Toxicology | journal | 0.552 Q3 | 69 | 71 | 140 | 2391 | 252 | 139 | 1.84 | 33.68 | 41.32 | |
37 | Biotechnology and Applied Biochemistry | journal | 0.479 Q3 | 81 | 61 | 205 | 2566 | 385 | 203 | 1.62 | 42.07 | 40.58 | |
38 | MCB Molecular and Cellular Biomechanics | journal | 0.460 Q3 | 31 | 16 | 52 | 458 | 62 | 52 | 0.89 | 28.63 | 18.97 | |
39 | Advances in Pharmacological Sciences | journal | 0.455 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
40 | Journal of Stem Cells | journal | 0.426 Q4 | 21 | 21 | 57 | 1745 | 71 | 56 | 0.97 | 83.10 | 34.78 | |
41 | Probiotics and Antimicrobial Proteins | journal | 0.343 Q4 | 52 | 32 | 61 | 1450 | 69 | 60 | 1.17 | 45.31 | 41.61 | |
42 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.270 Q4 | 53 | 63 | 297 | 1923 | 249 | 296 | 0.84 | 30.52 | 27.75 | |
43 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q4 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | 0.00 | |
44 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.144 Q4 | 16 | 51 | 162 | 1655 | 55 | 162 | 0.36 | 32.45 | 61.38 | |
45 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.135 Q4 | 14 | 26 | 59 | 1151 | 9 | 55 | 0.15 | 44.27 | 37.70 | |
46 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.107 Q4 | 40 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | 0.00 | |
47 | Human gene therapy methods | journal | 38 | 39 | 0 | 1614 | 0 | 0 | 0.00 | 41.38 | 37.33 | ||
48 | Molecular Therapy - Nucleic Acids | journal | 95 | 62 | 0 | 2345 | 0 | 0 | 0.00 | 37.82 | 34.55 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®